The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
Open accessAbstract
The Hypertension Detection and Follow-up Program followed up 10,940 persons for 5 years in a community-based, randomized, controlled trial of treatment for hypertension. Participants were randomized to one of two treatment groups, stepped care and referred care. The primary end point of the study was all-cause mortality, with morbid events involving the heart, brain, and kidney as secondary end points. Loss of renal function, ascertained by a change in serum creatinine, was among these secondary events. Baseline serum creatinine concentration had a significant prognostic value for 8-year mortality. For persons with a serum creatinine concentration greater than or equal to 1.7 mg/dl, 8-year mortality was more than three times that of all other participants. The estimated 5-year incidence of substantial decline in renal function was 21.7/1,000 in the stepped-care group and 24.6/1,000 in the referred-care group. Among persons with a baseline serum creatinine level between 1.5 and 1.7 mg/dl, the 5-year incidence of decline was 113.3/1,000 (stepped care) and 226.6/1,000 (referred care) (p less than 0.01). The incidence of decline in renal function was greater in men, blacks, and older adults, as well as in those with higher entry diastolic blood pressure. Among persons with a baseline serum creatinine level greater than or equal to 1.7 mg/dl, serum creatinine concentration declined by 25% or more in 28.6% of stepped-care and 25.2% of referred-care participants. Although the incidence of clinically significant hypercreatininemia in a hypertensive population is low, an elevated serum creatinine concentration is a very potent independent risk factor for mortality. The slightly lower rate of development of hypercreatininemia and the higher rate of improvement in stepped-care compared with referred-care participants is consistent with the belief that aggressive treatment of hypertension may reduce renal damage and the associated increased risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870 · cited 1×
“Specifically, the estimated cumulative proportion dying was computed as one minus the cumulative proportion surviving with the Cutler-Ederer estimator for the probability of surviving successive 3month intervals.(23) The Cutler-Ederer estimator, which does not take into account exact survival time, assumes that, on av…”
MethodON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTION
Bonsnes, R. W., & Taussky, H. H. (1945) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51334-5 · Cited by 1,989
Estimation of the probability of an event as a function of several independent variables
WALKER, S. H., & DUNCAN, D. B. (1967) · Biometrika · doi:10.1093/biomet/54.1-2.167 · Cited by 1,682
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
AMERY, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,476
(1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 993
(1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 554
Determination of Creatinine by Means of Automatic Chemical Analysis
Chasson, A. L., Grady, H. J., & Stanley, M. A. (1961) · American Journal of Clinical Pathology · doi:10.1093/ajcp/35.1_ts.83 · Cited by 552
Endogenous Creatinine in Serum and Urine.
Hare, R. S. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-74-17837 · Cited by 484
Racial Differences in the Incidence of Treatment for End-Stage Renal Disease
Rostand, S. G., Kirk, K. A., Rutsky, E. A., & Pate, B. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205273062106 · Cited by 400
The hypertension detection and follow-up program
(1976) · Preventive Medicine · doi:10.1016/0091-7435(76)90039-6 · Cited by 347
Effect of Transplantation on the Medicare End-Stage Renal Disease Program
Eggers, P. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180406 · Cited by 320
RACE, EDUCATION AND PREVALENCE OF HYPERTENSION12
HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM COOPERATIVE GROUP (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112476 · Cited by 216
THE AUSTRALIAN THERAPEUTIC TRIAL IN MILD HYPERTENSION
(1980) · The Lancet · doi:10.1016/s0140-6736(80)91730-4 · Cited by 215
CURB, J. D., FORD, C. E., PRESSEL, S., PALMIER, M., BABCOCK, C., & HAWKINS, M. (1985) · American Journal of Epidemiology · doi:10.1093/aje/121.5.754 · Cited by 204
Self-citationBlood Pressure Studies in 14 Communities: A Two-Stage Screen for Hypertension
(1977) · JAMA · doi:10.1001/jama.1977.03270490025018 · Cited by 172
Apparent Prevalence of Curable Hypertension in the Hypertension Detection and Follow-up Program
Lewin, A. J. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360030056011 · Cited by 112
Renal Function During Long-Term Treatment of Hypertension with Minoxidil
Mitchell, H. C., GRAHAM, R. M., & PETTINGER, W. A. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-676 · Cited by 99
End-Stage Renal Disease in Michigan
Weller, J. M., Wu, S.-C., Ferguson, W., & Hawthorne, V. M. (2008) · American Journal of Nephrology · doi:10.1159/000166912 · Cited by 56
Natural History of Hypertension in Renal Parenchymal Disease
Blythe, W. B. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80066-4 · Cited by 54
Hiatt, R. A., & FRIEDMAN, G. D. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.8.829 · Cited by 44
NOSOLOGICAL CODING OF CAUSE OF DEATH
Curb, J. D., BABCOCK, C., Pressel, S., Tung, B., Remington, R. D., & HAWKINS, C. M. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113613 · Cited by 40
Giumetti, D., Liu, K., Stamler, R., Schoenberger, J. A., Shekelle, R. B., & Stamler, J. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90002-7 · Cited by 24
Cited by
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Metadata
- Authors
- Shulman, N. B., Ford, C. E., Hall, W. D., Blaufox, M. D., Simon, D., Langford, H. G., & Schneider, K. A.
- Venue
- Hypertension
- Published
- 1989-05
- Volume
- 13
- Issue
- 5_supplement
- Pages
- I80-93
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2170716254
- Cited by
- 676
- References
- 23
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.